Elaboration of the Abstract
Abstracts should include until 2500 characters and include the following elements: (a) Title; b) Introduction; c) Aims; d) Methodology; e) Results; f) Conclusions.
Abstracts will be accepted in Portuguese, Spanish and English.
Researchs with humans, animals or genetically modified organisms, should be previously evaluated and approved by the Committee on Research Ethics, Committee on Ethics in the Use of Animals or the Committee on Biosafety, respectively. This information must be included in the text, in the item Methodology followed by the protocol number.
Abstracts should be sent exclusively by the event website.
Elaboration of the Paper
The instructions for authors can be consulted at the electronic address: http://revistas.unoeste.br/revistas/ojs/index.php/cv/about/submissions#authorGuidelines
The article should be typed in a single column, using Calibri 12 font, 1,5 spacing between lines, formatted on A4 paper (212 x 297 mm) with 2.0 cm of margins and tab of 1.25 cm for marking the beginning of each paragraph.
It should have the maximum extension of 20 pages (from cover to references) and contain the following sections separated by three lines: Titles, Abstract and Keywords, Full text including tables and figures with their respective titles and Legends, Acknowledgments and Conflict of Interest, References.
The pages should be numbered consecutively.
Title page:
The title page should include:
- Title should written in lowercase (except for the first letter), bold, and aligned to the left. Title should have up to 20 words.
- The name(s) of the author(s) and institutional affiliation
- The e-mail address, telephone and fax numbers of the corresponding author
Abstract:
Please provide an unstructured abstract with up to 150 words, placed in a single paragraph, spacing 1.0 lines. This section should contain the synthesis of the Purpose, Methods, Results and Conclusions (these subheadings should not be written).
Five keywords should be provided, in lowercase and comma-separated, for indexing. The Keywords must comply with the standards of the Index Medicus, which can be consulted at the electronic address: http://decs.bvs.br/
Text:
It should be divided into the following sections: (A) Introduction (include the aim in the last paragraph), (B) Methods, (C) Results and (D) Discussion (include conclusion in last paragraph). These subtitles should be written in bold with only the first capital letter. Sequential letters (A, B etc) should not be written.
A. Introduction and aim: should contain a brief review of the subject, which is sufficient for its contextualization. The last paragraph should be a justification with the scientific relevance of the study and the aim
B. Methods: should contain a description of the subjects (patients) or experimental model (laboratory animals) indicating that the study was approved by the Research Ethics Committee of the Research Institution or Hospital where the study was performed, following the guidelines of the National Council for Research Ethics (CONEP) based on the Helsinki Declaration and the Ethical Principles on Animal Experimentation of the Brazilian College of Animal Experimentation (Cobea) and the Federal Council of Veterinary Medicine (CFMV). Articles involving the use of genetically modified organisms must submit the opinion of the Biosafety Committee to which it was submitted.
C. Results: should be presented in logical sequence in the text, emphasizing only the important observations and avoiding the repetition of data presented in tables or figures, which should be numbered in sequence with Arabic numerals and inserted soon after their mention in the text.
Tables: They should be in MS Word (.doc or .docx), numbered and contain a concise title. Each table must be typed at 1.5 spacing between rows and its vertical lines should not be visible. If there is a need for captioning to define abbreviations or indicating statistically significant differences (p-value), it should be placed just below the table.
Figures: The denomination Figure should always be used for graphics, schematic drawings and photos. They should be numbered following their appearance in the text. The title should be placed immediately below, as well as the definition of abbreviations or indication of statistically significant differences (p value).
Graphics should be rendered in MS Exel (.xls; .xlsx or equivalent). The figures, photos and schematic drawings, after their original preparation, must be converted into the format for viewing (.jpg or .jpeg), as a good definition. Graphics, schematic drawings and photos can be colored.
All figures must be inserted in their places in the text and the files must also be sent separately (as supplementary material). The letters, numbers and symbols in the figures should be clear and large enough to be legible, even after reduction (if necessary, in the two-column layout).
D. Discussion and conclusion: should comment on the new and important aspects obtained from the study in relation to the information available in the most recent literature. You should avoid repeating results or information already presented in other sections. It is also important to highlight the implications of the findings, their limitations and recommendations for future studies. At the end of this section there should be a paragraph (without subheading) summarizing the authors' conclusions.
Acknowledgments and Conflict of Interest
This section may include: (i) acknowledgments to persons who have made contributions to the work, but who do not justify authorship, (ii) acknowledgments for technical, financial and material assistance, including governmental assistance, from pharmaceutical laboratories, companies or institutions.
A mention of Conflict of Interest should be included describing financial collaborations that may represent a potential conflict of interest and/or declaring no conflict of interest that could interfere with the impartiality of scientific work. Statement to be placed when there is no Conflict of Interest.
Paper with up to six authors
Silveira LR, Curi R. Regulação do metabolismo de glicose e ácido graxo no músculo esquelético durante o exercício físico. Arq Bras Endocrinol Metab. 2012;56(7):468-469. DOI: http://dx.doi.org/10.1590/S0004-27302012000700011
Nici L, ZuWallack RL. Pulmonary rehabilitation: future directions. Clin Chest Med. 2014;35(2):439-444. DOI: http://dx.doi.org/10.1016/j.ccm.2014.02.015
Tewari A, Mahendru V, Sinha A, Bilotta F. Antioxidants: The new frontier for translational research in cerebroprotection. J Anaesthesiol Clin Pharmacol. 2014;30(2):160-171. DOI: http://dx.doi.org/10.4103/0970-9185.130001
Paper with more than six authors
Wright FA, Sullivan PF, Brooks AI, Zou F, Sun W, Xia K et al. Heritability and genomics of gene expression in peripheral blood. Nature Gen. 2014;46(5):430-437. DOI: http://dx.doi.org/10.1038/ng.2951
Chang Y, Bruni R, Kloss B, Assur Z, Kloppmann E, Rost B et al. Structural basis for a pH-sensitive calcium leak across membranes. Science. 2014;344(6188):1131-1135. DOI: http://dx.doi.org/10.1126/science.1252043
Book
Tiidus PM. Skeletal muscle damage and repair. Champaign IL: Human Kinetics; 2008.